Literature DB >> 20944673

Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.

C Pangault1, P Amé-Thomas, P Ruminy, D Rossille, G Caron, M Baia, J De Vos, M Roussel, C Monvoisin, T Lamy, H Tilly, P Gaulard, K Tarte, T Fest.   

Abstract

Follicular lymphoma (FL) B cells contract tight connections with their microenvironment, which governs the pathogenesis and progression of the disease. Indeed, specific immune response gene signatures, obtained from whole biopsy samples, have been associated with patient survival. In this study, we performed gene expression profiling of purified B cell and non-B cell compartments obtained from FL and reactive lymph nodes. We identified 677 non-redundant genes defining the FL interface and involving 26 FL-specific functional networks. This approach highlighted an interleukin-4 (IL-4)-centered pathway associated with an activation of signal transducer and activator of transcription 6 (STAT6), which favors overexpression of IL-4-target genes. In addition, FL microenvironment was characterized by a strong enrichment in follicular helper T cells (T(FH)), as demonstrated through transcriptomic and flow cytometry analyses. The majority of phospho-STAT6(pos) B cells were located at the vicinity of cells expressing the programmed death 1 (PD-1) T(FH) marker. Moreover, purified FL-derived T(FH), expressed IL4 at very high levels compared with purified tonsil-derived T(FH) or non-T(FH) microenvironment. Altogether, our study demonstrated that tumor-infiltrating T(FH) specifically express functional IL-4 in FL, creating an IL-4-dependent T(FH)-B cell axis. This cross talk could sustain FL pathogenesis and represent a new potential therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20944673      PMCID: PMC3317889          DOI: 10.1038/leu.2010.223

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  50 in total

1.  Selective inhibition of class switching to IgG and IgE by recruitment of the HoxC4 and Oct-1 homeodomain proteins and Ku70/Ku86 to newly identified ATTT cis-elements.

Authors:  András Schaffer; Edmund C Kim; Xiaoping Wu; Hong Zan; Lucia Testoni; Szilvia Salamon; Andrea Cerutti; Paolo Casali
Journal:  J Biol Chem       Date:  2003-04-02       Impact factor: 5.157

2.  Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas.

Authors:  K Warzocha; P Ribeiro; N Renard; J Bienvenu; C Charlot; B Coiffier; G Salles
Journal:  Cancer Immunol Immunother       Date:  2000-11       Impact factor: 6.968

3.  Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays.

Authors:  Hervé Husson; Elizabeth G Carideo; Donna Neuberg; Joachim Schultze; Olivier Munoz; Peter W Marks; John W Donovan; Antoinette C Chillemi; Peter O'Connell; Arnold S Freedman
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

4.  The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.

Authors:  Teresa Marafioti; Jennifer C Paterson; Erica Ballabio; Andreas Chott; Yasodha Natkunam; Manuel Rodriguez-Justo; Anne Plonquet; Socorro M Rodriguez-Pinilla; Wolfram Klapper; Martin-L Hansmann; Stefano A Pileri; Peter G Isaacson; Harald Stein; Miguel A Piris; David Y Mason; Philippe Gaulard
Journal:  Haematologica       Date:  2010-03       Impact factor: 9.941

5.  Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.

Authors:  Brian F Skinnider; Andrew J Elia; Randy D Gascoyne; Bruce Patterson; Lorenz Trumper; Ursula Kapp; Tak W Mak
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

6.  Interleukin-4-mediated protection of primary B cells from apoptosis through Stat6-dependent up-regulation of Bcl-xL.

Authors:  Andrea L Wurster; Vikki L Rodgers; Morris F White; Thomas L Rothstein; Michael J Grusby
Journal:  J Biol Chem       Date:  2002-05-22       Impact factor: 5.157

7.  HGAL, a lymphoma prognostic biomarker, interacts with the cytoskeleton and mediates the effects of IL-6 on cell migration.

Authors:  Xiaoqing Lu; Jun Chen; Raquel Malumbres; Elena Cubedo Gil; David M Helfman; Izidore S Lossos
Journal:  Blood       Date:  2007-09-06       Impact factor: 22.113

8.  Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.

Authors:  Chrystelle Guiter; Isabelle Dusanter-Fourt; Christiane Copie-Bergman; Marie-Laure Boulland; Sabine Le Gouvello; Philippe Gaulard; Karen Leroy; Flavia Castellano
Journal:  Blood       Date:  2004-03-25       Impact factor: 22.113

9.  High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial.

Authors:  Danielle Canioni; Gilles Salles; Nicolas Mounier; Nicole Brousse; Marie Keuppens; Frank Morchhauser; Thierry Lamy; Anne Sonet; Marie-Christine Rousselet; Charles Foussard; Luc Xerri
Journal:  J Clin Oncol       Date:  2007-12-17       Impact factor: 44.544

10.  Lymphomas can develop from B cells chronically helped by idiotype-specific T cells.

Authors:  Michael M Zangani; Marianne Frøyland; Gao Yue Qiu; Leonardo A Meza-Zepeda; Jeffery L Kutok; Keith M Thompson; Ludvig A Munthe; Bjarne Bogen
Journal:  J Exp Med       Date:  2007-05-07       Impact factor: 14.307

View more
  51 in total

1.  Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells.

Authors:  P Amé-Thomas; J Le Priol; H Yssel; G Caron; C Pangault; R Jean; N Martin; T Marafioti; P Gaulard; T Lamy; T Fest; G Semana; K Tarte
Journal:  Leukemia       Date:  2011-10-21       Impact factor: 11.528

2.  DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma.

Authors:  Rada Amin; Frédéric Mourcin; Fabrice Uhel; Céline Pangault; Philippe Ruminy; Loic Dupré; Marion Guirriec; Tony Marchand; Thierry Fest; Thierry Lamy; Karin Tarte
Journal:  Blood       Date:  2015-08-13       Impact factor: 22.113

3.  Interleukin 4 induces the apoptosis of mouse microglial cells by a caspase-dependent mechanism.

Authors:  Javier A Soria; Daniela S Arroyo; Emilia A Gaviglio; Maria C Rodriguez-Galan; Ji Ming Wang; Pablo Iribarren
Journal:  Neurobiol Dis       Date:  2011-05-23       Impact factor: 5.996

Review 4.  Follicular helper T cells: implications in neoplastic hematopathology.

Authors:  Philippe Gaulard; Laurence de Leval
Journal:  Semin Diagn Pathol       Date:  2011-08       Impact factor: 3.464

5.  Association of peripheral CD4+ CXCR5+ T cells with chronic lymphocytic leukemia.

Authors:  Zhanshan Cha; Yan Zang; Huijun Guo; James R Rechlic; Lindsay M Olasnova; Haihui Gu; Xiaohua Tu; Haihan Song; Baohua Qian
Journal:  Tumour Biol       Date:  2013-06-27

6.  Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphoma.

Authors:  Matthew J Ahearne; Kaljit Bhuller; Roger Hew; Hazem Ibrahim; Kikkeri Naresh; Simon D Wagner
Journal:  Virchows Arch       Date:  2014-07-11       Impact factor: 4.064

Review 7.  From genetics to the clinic: a translational perspective on follicular lymphoma.

Authors:  Sarah Huet; Pierre Sujobert; Gilles Salles
Journal:  Nat Rev Cancer       Date:  2018-02-09       Impact factor: 60.716

8.  Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop.

Authors:  Roch Houot; Philippe Gaulard; Robert Schreiber; Ira Mellman; Olivier Lambotte; Pierre G Coulie; Thierry Fest; Alan Korman; Ronald Levy; Margaret Shipp; Karin Tarte; Holbrook Kohrt; Aurélien Marabelle; Stephen Ansell; Hervé Watier; Andrea van Elsas; Arun Balakumaran; Frederick Arce Vargas; Sergio A Quezada; Gilles Salles; Daniel Olive
Journal:  Oncoimmunology       Date:  2016-05-19       Impact factor: 8.110

9.  T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling.

Authors:  Sarah E Josefsson; Kanutte Huse; Arne Kolstad; Klaus Beiske; Daniela Pende; Chloé B Steen; Else Marit Inderberg; Ole Christian Lingjærde; Bjørn Østenstad; Erlend B Smeland; Ronald Levy; Jonathan M Irish; June H Myklebust
Journal:  Clin Cancer Res       Date:  2017-12-07       Impact factor: 12.531

10.  Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.

Authors:  Michael Boice; Darin Salloum; Frederic Mourcin; Viraj Sanghvi; Rada Amin; Elisa Oricchio; Man Jiang; Anja Mottok; Nicolas Denis-Lagache; Giovanni Ciriello; Wayne Tam; Julie Teruya-Feldstein; Elisa de Stanchina; Wing C Chan; Sami N Malek; Daisuke Ennishi; Renier J Brentjens; Randy D Gascoyne; Michel Cogné; Karin Tarte; Hans-Guido Wendel
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.